Michael Markels Jr., VP, Business Development at NeurogesX Inc (NGSX), bought 3,000 shares at $6.42 ($19K) on 2007-11-20, disclosed to the SEC on 2007-11-21.
Open-market purchase of $19k NGSX by VP, Business Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.35 | 100 | $635 | 3.3% |
| 2 | $6.36 | 200 | $1K | 6.6% |
| 3 | $6.42 | 1,000 | $6K | 33.2% |
| 4 | $6.48 | 1,700 | $11K | 57.0% |
| Total | $6.45 avg | 3,000 | $19K | 100% |
| Filing → |
| NGSX | BUY | 2008-12-08 | $3K | — | Filing → |
| NGSX | BUY | 2008-11-25 | $3K | — | Filing → |
| NGSX | BUY | 2008-11-20 | $3K | — | Filing → |